AbbVie Inc.
Bromodomain Inhibitors

Last updated:

Abstract:

Provided are compounds of formula (I), wherein R.sup.1, Y, X.sup.1, X.sup.2, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6 and m have any of the values defined in the specification and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS. Also provided are pharmaceutical compositions comprising compounds of formula (I). ##STR00001##

Status:
Application
Type:

Utility

Filling date:

14 Oct 2016

Issue date:

13 Feb 2020